首页> 外文期刊>Scandinavian journal of infectious diseases. >Diagnostic value of bronchoalveolar lavage in community-acquired pneumonia in a routine setting: a study on patients treated in a Finnish university hospital.
【24h】

Diagnostic value of bronchoalveolar lavage in community-acquired pneumonia in a routine setting: a study on patients treated in a Finnish university hospital.

机译:常规情况下支气管肺泡灌洗对社区获得性肺炎的诊断价值:一项在芬兰大学医院接受治疗的患者的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Only a few previous studies have focused on the use or bronchoalveolar lavage (BAL) in patients with community-acquired pneumonia (CAP). Our aim was to evaluate the diagnostic value of BAL in CAP in a routine clinical setting. 71 disease episodes were retrospectively analysed. The patients had undergone BAL for serious or slowly responding pneumonia. All procedures were performed during antimicrobial treatment of the patient. BAL fluid was cultivated for bacteria, fungi, and viruses. In 68 episodes, 1 or several specific polymerase chain reaction tests were performed. Only 1 (1.3%) quantitative bacterial culture was considered diagnostic for CAP, and indicated a change of antimicrobial treatment. The diagnostic yield increased to 9.8% when other methods were used. A respiratory virus was the only aetiology in 3 (6.0%) patients. In slowly responding pneumonia, also hospital-acquired pathogens and malignancies were identified, resulting in a total diagnostic yield of 20.0%. Thus, even when a large array of diagnostic assays was applied, the value of BAL in pretreated patients with CAP was very small, and its therapeutic implications minimal. In a subgroup of slowly responding pneumonia, the procedure was of some usefulness even after commencement of antimicrobial treatment.
机译:以前只有少数研究集中在社区获得性肺炎(CAP)患者使用或支气管肺泡灌洗(BAL)。我们的目的是评估常规临床环境中BAL在CAP中的诊断价值。回顾性分析71例疾病发作。患者因严重或缓慢反应的肺炎而接受了BAL治疗。所有程序均在对患者进行抗菌治疗期间执行。培养BAL液中的细菌,真菌和病毒。在68集中,进行了1项或多项特定的聚合酶链反应测试。仅1例(1.3%)定量细菌培养被认为可诊断CAP,并表明改变了抗菌治疗方法。使用其他方法时,诊断产率提高到9.8%。呼吸道病毒是3例(6.0%)患者的唯一病因。在缓慢反应的肺炎中,还鉴定了医院获得的病原体和恶性肿瘤,导致总诊断率为20.0%。因此,即使应用了大量的诊断方法,在CAP预处理患者中BAL的价值也很小,其治疗意义也很小。在缓慢反应的肺炎亚组中,该方法即使在开始抗菌治疗后仍然有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号